Diabetes

By Heather Mack December 2, 2016
Germantown, Maryland-based Senseonics, which is working on a long-term implantable continuous glucose monitor called Eversense, has expanded its exclusive distribution agreement with Roche. Now, Roche will have exclusive rights to promote, market and sell the Eversense product line to diabetes clinics and patients in in most of Europe (excluding Scandinavia and Finland), the Middle East (except...
By Jonah Comstock November 17, 2016
Dr. Dennis Ausiello, director of the Center for Assessment Technology and Continuous Health (CATCH) at Massachusetts General Hospital, says the smartphone is “the greatest medical device ever made”. As part of a talk at the Xconomy Forum in Boston today, Ausiello spoke about some lessons learned from GlucoSuccess, the Apple ResearchKit project launched by CATCH. “The thing that we learned was...
By Heather Mack November 17, 2016
Eli Lilly and Company has developed an app for people living with Type II diabetes who use Trulicity, the company’s once-per-week injectable diabetes medication that also works with a click-activated pen. The app, which has been fully functionally since September, is currently available free on iOS to anyone with a Trulicity prescription. “It’s important for people to successfully start any...
By Heather Mack November 16, 2016
Mountain View, California-based Livongo Health, a chronic disease management company, has launched a new capability on its smart blood glucose meter. The device now employs one of the most basic – yet perhaps underrated – features of a smartphone: the ability to download over-the-air updates. The Livongo meter, a smart glucose meter that the company says is the first such device to offer...
By Heather Mack November 11, 2016
Israel-based DarioHealth, which makes a smartphone-connected blood glucose monitor, has made significant headway in the US, Australian and Canadian markets, seling 5,500 devices in the US this quarter and 8,500 worldwide. The company launched in the US in March, and quickly built up a customer base with more than 100 percent increase in growth by the second quarter. Coasting on that wave of new...
By Heather Mack November 9, 2016
A new tool to diagnose diabetes is in the works, and it’s a far cry from the often painful and invasive method of drawing blood. Researchers at the University of Oxford are developing a portable device, similar to breathalyzers used to detect blood alcohol level, that they believe can potentially diagnose diabetes non-invasively and monitor glucose levels. Head researchers Robert Peverall and his...
By Jonah Comstock November 9, 2016
Senseonics, the Germantown, Maryland-based company which went public in January and is working on a longterm implantable continuous glucose monitor, has submitted its PMA application to the FDA, President and CEO Tim Goodnow said on the company's third quarter earnings call last week. In addition, the company continues to work on a second generation device and its first pediatric clinical trial...
By Jonah Comstock October 24, 2016
Three bits of news this week from companies working on diabetes management offerings might be of interest to anyone interested in digital health.  First off, NovioSense, a Dutch company developing a smartphone-connected tear-based glucose sensor that sits in the lower eyelid, secured an undisclosed amount of new funding. The round included existing investors Health Innovations, Topfonds...
By Heather Mack October 13, 2016
The digital behavioral health coaching program from Omada Health has been shown to reduce overweight and obese seniors' risk of developing type 2 diabetes and heart disease by helping them lose weight and adopt healthier behaviors, according to a new study. Over a three-year span, researchers looked at 1,121 adults age 65 or older who had a baseline body mass index of 24 or higher, plus...
By Jonah Comstock October 11, 2016
Patients Pending, a London-based health startup founded by one of the co-creators of Skype and his brother, has announced that it will follow up its Timesulin insulin pen cap with a Bluetooth-connected insulin pen cap, which the company hopes will help create smart dosing systems for patients with Type 1 diabetes who don’t use an insulin pump.  “Our hypothesis has been, so much of the investment...

Editor's Pick